Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4862005
Max Phase: Preclinical
Molecular Formula: C83H137N25O39
Molecular Weight: 2109.15
Molecule Type: Unknown
Associated Items:
ID: ALA4862005
Max Phase: Preclinical
Molecular Formula: C83H137N25O39
Molecular Weight: 2109.15
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1NC(=O)CNC(=O)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
Standard InChI: InChI=1S/C83H137N25O39/c1-34(2)21-44(81(143)107-19-9-12-50(107)75(138)95-39(11-7-8-18-84)68(131)104-61(35(3)115)77(140)90-25-57(123)89-26-58(124)93-49(32-113)83(145)146)98-73(136)45(28-109)99-76(139)51-13-10-20-108(51)82(144)48(31-112)102-74(137)47(30-111)101-78(141)62(36(4)116)105-69(132)41(15-17-54(87)120)94-72(135)46(29-110)100-79(142)63(37(5)117)106-71(134)43(23-60(126)127)97-70(133)42(96-67(130)40(14-16-53(86)119)92-56(122)24-85)22-55(121)88-27-59(125)103-80-64(91-38(6)118)66(129)65(128)52(33-114)147-80/h34-37,39-52,61-66,80,109-117,128-129H,7-33,84-85H2,1-6H3,(H2,86,119)(H2,87,120)(H,88,121)(H,89,123)(H,90,140)(H,91,118)(H,92,122)(H,93,124)(H,94,135)(H,95,138)(H,96,130)(H,97,133)(H,98,136)(H,99,139)(H,100,142)(H,101,141)(H,102,137)(H,103,125)(H,104,131)(H,105,132)(H,106,134)(H,126,127)(H,145,146)/t35-,36-,37-,39+,40+,41+,42+,43+,44+,45+,46+,47+,48+,49+,50+,51+,52-,61+,62+,63+,64-,65-,66-,80-/m1/s1
Standard InChI Key: RBTCVHROCRUVLJ-RMDYKJTGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2109.15 | Molecular Weight (Monoisotopic): 2107.9505 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Prabhu SK, Li C, Zong G, Zhang R, Wang LX.. (2021) Comparative studies on the substrate specificity and defucosylation activity of three α-l-fucosidases using synthetic fucosylated glycopeptides and glycoproteins as substrates., 42 [PMID:34126284] [10.1016/j.bmc.2021.116243] |
Source(1):